Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?
Crossref DOI link: https://doi.org/10.1007/s12029-020-00497-7
Published Online: 2020-09-01
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dikilitas, Mustafa
Text and Data Mining valid from 2020-09-01
Version of Record valid from 2020-09-01
Article History
First Online: 1 September 2020